These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 1691513

  • 1. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues.
    Wang SC, Wikström MG, White DL, Klaveness J, Holtz E, Rongved P, Moseley ME, Brasch RC.
    Radiology; 1990 May; 175(2):483-8. PubMed ID: 1691513
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent.
    Sirlin CB, Vera DR, Corbeil JA, Caballero MB, Buxton RB, Mattrey RF.
    Acad Radiol; 2004 Dec; 11(12):1361-9. PubMed ID: 15596374
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver.
    Pavone P, Patrizio G, Buoni C, Tettamanti E, Passariello R, Musu C, Tirone P, Felder E.
    Radiology; 1990 Jul; 176(1):61-4. PubMed ID: 2353112
    [Abstract] [Full Text] [Related]

  • 6. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
    Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC.
    Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
    [Abstract] [Full Text] [Related]

  • 7. In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G, Schmitt-Willich H, Frenzel T, Press WR, Weinmann HJ.
    Invest Radiol; 1991 Nov; 26(11):969-74. PubMed ID: 1743920
    [Abstract] [Full Text] [Related]

  • 8. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
    Patrizio G, Pavone P, Cardone G, Pietroletti R, Passariello R, Tettamanti E, Musu C, Felder E.
    Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
    [Abstract] [Full Text] [Related]

  • 9. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O, Mühler A, Vexler V, Berthezène Y, Brasch RC.
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [Abstract] [Full Text] [Related]

  • 10. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.
    Shuter B, Tofts PS, Wang SC, Pope JM.
    Magn Reson Imaging; 1996 Aug; 14(3):243-53. PubMed ID: 8725190
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbits.
    Loubeyre P, Canet E, Zhao S, Benderbous S, Amiel M, Revel D.
    Invest Radiol; 1996 May; 31(5):288-93. PubMed ID: 8724128
    [Abstract] [Full Text] [Related]

  • 13. In vivo MR evaluation of Gd-DTPA conjugated to dextran in normal rabbits.
    Li KC, Quisling RG, Armitage FE, Richardson D, Mladinich C.
    Magn Reson Imaging; 1992 May; 10(3):439-44. PubMed ID: 1383670
    [Abstract] [Full Text] [Related]

  • 14. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ, Kümmel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, Schwarz W, Müller PK, Bechstein WO, Mack MG, Söllner O, Felix R.
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [Abstract] [Full Text] [Related]

  • 15. MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA.
    Runge VM, Jacobson S, Wood ML, Kaufman D, Adelman LS.
    Radiology; 1988 Mar; 166(3):835-8. PubMed ID: 3401296
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G, Frenzel T, Schmitt-Willich H.
    Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
    [Abstract] [Full Text] [Related]

  • 17. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
    Kunimasa J, Inui K, Hori R, Kawamura Y, Endo K.
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
    [Abstract] [Full Text] [Related]

  • 18. Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA.
    Strich G, Hagan PL, Gerber KH, Slutsky RA.
    Radiology; 1985 Mar; 154(3):723-6. PubMed ID: 3969477
    [Abstract] [Full Text] [Related]

  • 19. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns.
    Vexler VS, Clément O, Schmitt-Willich H, Brasch RC.
    J Magn Reson Imaging; 1994 Mar; 4(3):381-8. PubMed ID: 8061437
    [Abstract] [Full Text] [Related]

  • 20. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P, Runge VM, Bücker A, Schürholz H, Reith W, Robert P, Jackson C, Lanz T, Schneider G.
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.